ABIVAX Société Anonyme Share Price & Technical Analysis
ABVX · $126.4 (+3.62%)
Healthcare / Biotechnology
$126.4
+3.62%
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials fo…
Price chart
Seasonality
May has 1 positive and 2 negative years (last 4 years shown)
4% return in May, -11% avg return in past 3 year May month.
-4% return in 2026, 294% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -19% | 13% | -6% | 4% | 4% | – | – | – | – | – | – | – | -4% |
| 25 | -17% | 31% | -16% | 13% | -17% | 26% | 821% | 16% | 6% | 22% | 23% | 8% | 916% |
| 24 | 26% | 2% | 3% | 4% | -6% | -4% | -13% | 7% | -9% | -10% | -18% | -11% | -30% |
| 23 | – | – | – | – | – | – | – | – | – | -21% | 12% | 5% | -4% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.59B
P/E ratio
—
52W high
$148.8
52W low
$5.62
Volume
12,14,296
Beta
-0.19
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ABIVAX Société Anonyme share price today?
- ABIVAX Société Anonyme (ABVX) last traded around $126.4 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ABVX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ABVX. Download the app for real-time alerts.
- How can I analyze ABIVAX Société Anonyme stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.